Twenty years of metallo-neurobiology: where to now? (Q36997762)

17 August 2017

1 reference

title

Twenty years of metallo-neurobiology: where to now? (English)

1 reference

17 August 2017

1 reference

Cyril C Curtain

2

0 references

Ashley I. Bush

object named as

Ashley I Bush

series ordinal

1

0 references

publication date

10 November 2007

1 reference

European Biophysics Journal

17 August 2017

1 reference

17 August 2017

37

1 reference

17 August 2017

3

1 reference

17 August 2017

241-245

1 reference

https://scigraph.springernature.com/pub.10.1007/s00249-007-0228-1

17 August 2017

0 references

cites work

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00249-007-0228-1

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00249-007-0228-1

Proteolysis of AA amyloid fibril proteins by matrix metalloproteinases-1, -2, and -3.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00249-007-0228-1

Mechanisms of copper ion mediated Huntington's disease progression

21 January 2018

1 reference

12 December 2020

High levels of genetic change in rodents of Chernobyl

1 reference

12 December 2020

4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

1 reference

12 December 2020

Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase

1 reference

12 December 2020

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

12 December 2020

Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

1 reference

12 December 2020

Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

1 reference

12 December 2020

Stimulation-induced uptake and release of zinc in hippocampal slices

1 reference

12 December 2020

The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity

1 reference

12 December 2020

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

1 reference

12 December 2020

Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity

1 reference

12 December 2020

Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge.

1 reference

12 December 2020

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

1 reference

12 December 2020

Amyloid-beta-peptide reduces copper(II) to copper(I) independent of its aggregation state.

1 reference

12 December 2020

Widespread peroxynitrite-mediated damage in Alzheimer's disease.

1 reference

12 December 2020

Copper, iron and zinc in Alzheimer's disease senile plaques.

1 reference

12 December 2020

Involvement of oxidative stress in Alzheimer disease

1 reference

12 December 2020

Enhanced oligomerization of the alpha-synuclein mutant by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.

1 reference

12 December 2020

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

1 reference

12 December 2020

The cellular prion protein binds copper in vivo

1 reference

12 December 2020

Oxidative damage in Alzheimer's.

1 reference

12 December 2020

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

1 reference

12 December 2020

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

1 reference

12 December 2020

Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal

1 reference

12 December 2020

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

1 reference

12 December 2020

Rapid induction of Alzheimer A beta amyloid formation by zinc.

1 reference

12 December 2020

Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.

1 reference

12 December 2020

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

1 reference

12 December 2020

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

1 reference

12 December 2020

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

1 reference

12 December 2020

Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid

1 reference

12 December 2020

Alzheimer's disease, beta-amyloid protein and zinc

1 reference

12 December 2020

Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence

1 reference

12 December 2020

Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome

1 reference

12 December 2020

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.

1 reference

12 December 2020

The cellular prion protein binds copper in vivo

1 reference

12 December 2020

10.1007/S00249-007-0228-1

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17994233